The identification of nerves in the tumor microenvironment has ushered in a new area of
research in cancer biology. Numerous studies demonstrate the presence of various types of …

Abstract Purpose Prostate cancer (PCa) is the second most commonly diagnosed cancer in
men in Western and Asian countries. Serum prostate-specific antigen (PSA) test has been …

Metabolomics is a promising technology for the application of translational medicine to
cardiovascular risk. Here, we applied a liquid chromatography/tandem mass spectrometry …

Background The relationship between sodium-glucose cotransporter 2 (SGLT2) inhibitors
and prostate cancer is still unknown. Although these inhibitors can influence tumor …

Background Prevalent urological cancers, including kidney, prostate, bladder, and testicular
cancers, contribute significantly to global cancer incidence and mortality. Metabolomics …

Prostate cancer (PCa), bladder cancer (BCa), and renal cell carcinoma (RCC) are the most
prevalent cancer among urological cancers. However, there are no cancer-specific …

Prostate cancer (PCa) is a global health concern, ranking as the most common cancer
among men in Western countries. Traditional diagnostic methods are invasive with adverse …

Metabolic reprogramming of cancer cells is a hallmark of cancer, in which the polar
metabolites involving aerobic glycolysis, pentose phosphate pathway (PPP), tricarboxylic …

Abstract Background Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are
prevalent conditions affecting a significant portion of the male population, particularly with …

Abstract Background Prostate cancer (PCa) is still a serious male malignant disease across
the world. However, no exact pathogenesis had been explained. Although adenylosuccinate …